Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
23.85
+1.15 (5.07%)
At close: Feb 17, 2026, 4:00 PM EST
24.32
+0.47 (1.97%)
After-hours: Feb 17, 2026, 6:18 PM EST

Innoviva Revenue

Innoviva had revenue of $107.80M in the quarter ending September 30, 2025, with 20.44% growth. This brings the company's revenue in the last twelve months to $388.52M, up 10.14% year-over-year. In the year 2024, Innoviva had annual revenue of $5.17M with 14.24% growth.

Revenue (ttm)
$388.52M
Revenue Growth
+10.14%
P/S Ratio
3.95
Revenue / Employee
$3,059,220
Employees
127
Market Cap
1.78B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.17M645.00K14.24%
Dec 31, 20234.53M-326.81M-98.63%
Dec 31, 2022331.34M-60.53M-15.45%
Dec 31, 2021391.87M55.07M16.35%
Dec 31, 2020336.79M75.78M29.03%
Dec 31, 2019261.02M12.00K-
Dec 31, 2018261.00M43.79M20.16%
Dec 31, 2017217.22M83.65M62.63%
Dec 31, 2016133.57M79.62M147.58%
Dec 31, 201553.95M45.52M539.74%
Dec 31, 20148.43M3.90M86.08%
Dec 31, 20134.53M-1.08M-19.26%
Dec 31, 20125.61M-18.90M-77.10%
Dec 31, 201124.51M289.00K1.19%
Dec 31, 201024.22M-151.00K-0.62%
Dec 31, 200924.37M1.28M5.53%
Dec 31, 200823.10M1.09M4.97%
Dec 31, 200722.00M2.42M12.33%
Dec 31, 200619.59M7.53M62.49%
Dec 31, 200512.05M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ardelyx398.23M
Immunocore Holdings379.59M
MannKind313.79M
Zymeworks134.48M
Tango Therapeutics66.50M
Agios Pharmaceuticals54.03M
Precigen6.31M
Oculis Holding AG992.00K
Revenue Rankings